Tower Research Capital LLC (Trc) Tg Therapeutics, Inc. Transaction History
Tower Research Capital LLC (Trc)
- $3.39 Billion
- Q3 2025
A detailed history of Tower Research Capital LLC (Trc) transactions in Tg Therapeutics, Inc. stock. As of the latest transaction made, Tower Research Capital LLC (Trc) holds 5,197 shares of TGTX stock, worth $161,107. This represents 0.01% of its overall portfolio holdings.
Number of Shares
5,197
Previous 12,166
57.28%
Holding current value
$161,107
Previous $437,000
57.21%
% of portfolio
0.01%
Previous 0.01%
Shares
32 transactions
Others Institutions Holding TGTX
# of Institutions
399Shares Held
92.6MCall Options Held
1.77MPut Options Held
1.9M-
Vanguard Group Inc Valley Forge, PA15.5MShares$481 Million0.01% of portfolio
-
Black Rock Inc. New York, NY11.4MShares$353 Million0.0% of portfolio
-
State Street Corp Boston, MA8.1MShares$251 Million0.01% of portfolio
-
Clearbridge Investments, LLC New York, NY4.64MShares$144 Million0.13% of portfolio
-
Soleus Capital Management, L.P. Greenwich, CT3.84MShares$119 Million8.45% of portfolio
About TG THERAPEUTICS, INC.
- Ticker TGTX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 145,274,000
- Market Cap $4.5B
- Description
- TG Therapeutics, Inc., a commercial stage biopharmaceutical company, focuses on the acquisition, development, and commercialization of novel treatments for B-cell malignancies and autoimmune diseases. Its therapeutic product candidates include Ublituximab, an investigational glycoengineered monoclonal antibody for the treatment of B-cell non-hod...